Medicare Part B: Expenditures For New Drugs Concentrated Among A Few Drugs, And Most Were Costly For Beneficiaries

Publisher: United States. Government Accountability Office
Coverage: October 23, 2015

Volumes:

GAO-16-12 (2015-10-23)